Pharmacia & Upjohn's new nicotine product, Nicotrol Inhaler, has beenapproved and launched in the USA, to help smokers quit the habit. The company says it is the first product to provide smokers with a hand-to-mouth administration, which may satisfy some of the "ritual" elements of smoking, as well as supplying nicotine to alleviate craving.
Pivotal trials have shown that compared to a placebo, Nicotrol Inhaler doubled the likelihood that a smoker would remain abstinent for a year.
The product will be available on prescription in the USA. It is already sold over-the-counter in Denmark, Sweden and Italy, and has OTC applications pending in five other countries, including the UK. Prescription sale is approved in the Netherlands, while applications are pending in five other countries. P&U also markets patch and nasal spray formulations.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze